Can we use artificial intelligence (AI) to predict where a brain tumour might recur at the point of first diagnosis in order to pre-emptively treat it to stop recurrence?
 
Dr Francesca Cozzi (a PhD student at the University of Cambridge) and Dr Curtis Holliman (Associate Professor in the Mathematics Department at The Catholic University of America, USA) believe this will eventually be possible.
 
In this exciting conversation they talk about their collaboration to find a mechanism to mathematically model the progression of glioblastoma. They highlight why it is important to achieve this in an explainable way using AI, to keep the process of decision making transparent and interpretable to self-validate the models they develop.

Integrated Cancer Medicine: Research in Focus

Using AI to mathematically model the progression of glioblastoma

The Cancer Research UK Cambridge Centre unites over 1,000 world-leading biologists, chemists, physicists, engineers, mathematicians, computer scientists, clinicians, nurses and allied healthcare professionals from across Cambridge, UK to tackle cancer from every angle.

Our mission is to end death and disease caused by cancer through research, treatment and education. We are detecting cancer at its earliest stage and are developing personalised treatments for every patient through facilitating new collaborations and driving the translation of new scientific discoveries into clinical applications to improve patient care. By working together across a range of different disciplines, our members are breaking down the barriers between the laboratory and the clinic, enabling patients to benefit from the latest innovations in cancer science.